88 related articles for article (PubMed ID: 28895065)
1. Structural Characterization of the Trimerization of TRAF6 Protein Through Molecular Dynamics Simulations.
Biswas R; Bagchi A
Interdiscip Sci; 2019 Sep; 11(3):428-436. PubMed ID: 28895065
[TBL] [Abstract][Full Text] [Related]
2. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
[TBL] [Abstract][Full Text] [Related]
3. Structure based virtual screening of natural products to disrupt the structural integrity of TRAF6 C-terminal domain homotrimer.
Biswas R; Chowdhury N; Biswas S; Roy R; Bagchi A
J Mol Graph Model; 2019 Dec; 93():107428. PubMed ID: 31493661
[TBL] [Abstract][Full Text] [Related]
4. E2 interaction and dimerization in the crystal structure of TRAF6.
Yin Q; Lin SC; Lamothe B; Lu M; Lo YC; Hura G; Zheng L; Rich RL; Campos AD; Myszka DG; Lenardo MJ; Darnay BG; Wu H
Nat Struct Mol Biol; 2009 Jun; 16(6):658-66. PubMed ID: 19465916
[TBL] [Abstract][Full Text] [Related]
5. A structural perspective on the interactions of TRAF6 and Basigin during the onset of melanoma: A molecular dynamics simulation study.
Biswas R; Ghosh S; Bagchi A
J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28612997
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of TRAF1 TRAF domain and its implications in the TRAF1-mediated intracellular signaling pathway.
Kim CM; Choi JY; Bhat EA; Jeong JH; Son YJ; Kim S; Park HH
Sci Rep; 2016 May; 6():25526. PubMed ID: 27151821
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for self-association and receptor recognition of human TRAF2.
Park YC; Burkitt V; Villa AR; Tong L; Wu H
Nature; 1999 Apr; 398(6727):533-8. PubMed ID: 10206649
[TBL] [Abstract][Full Text] [Related]
8. The Structure and Ubiquitin Binding Properties of TRAF RING Heterodimers.
Das A; Middleton AJ; Padala P; Ledgerwood EC; Mace PD; Day CL
J Mol Biol; 2021 Apr; 433(8):166844. PubMed ID: 33539883
[TBL] [Abstract][Full Text] [Related]
9. TRAF trimers form immune signalling networks via RING domain dimerization.
Das A; Foglizzo M; Padala P; Zhu J; Day CL
FEBS Lett; 2023 May; 597(9):1213-1224. PubMed ID: 36310378
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
11. Structural Characterization of TRAF6 N-Terminal for Therapeutic Uses and Computational Studies on New Derivatives.
Guven O; Sever B; Başoğlu-Ünal F; Ece A; Tateishi H; Koga R; Radwan MO; Demir N; Can M; Dilsiz Aytemir M; Inoue JI; Otsuka M; Fujita M; Ciftci H; DeMirci H
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004473
[TBL] [Abstract][Full Text] [Related]
12. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
Hu L; Xu J; Xie X; Zhou Y; Tao P; Li H; Han X; Wang C; Liu J; Xu P; Neculai D; Xia Z
Nat Commun; 2017 Oct; 8(1):814. PubMed ID: 28993672
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and functional analysis of TRAF6 in orange-spotted grouper (Epinephelus coioides).
Li YW; Li X; Xiao XX; Zhao F; Luo XC; Dan XM; Li AX
Dev Comp Immunol; 2014 May; 44(1):217-25. PubMed ID: 24378225
[TBL] [Abstract][Full Text] [Related]
14. Siah ubiquitin ligase is structurally related to TRAF and modulates TNF-alpha signaling.
Polekhina G; House CM; Traficante N; Mackay JP; Relaix F; Sassoon DA; Parker MW; Bowtell DD
Nat Struct Biol; 2002 Jan; 9(1):68-75. PubMed ID: 11742346
[TBL] [Abstract][Full Text] [Related]
15. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of the RING domain from human TRAF6 by 15N NMR spectroscopy: implications for biological function.
Markin CJ; Saltibus LF; Spyracopoulos L
Biochemistry; 2008 Sep; 47(38):10010-7. PubMed ID: 18759459
[TBL] [Abstract][Full Text] [Related]
17. Identification and analyses of natural compounds as potential inhibitors of TRAF6-Basigin interactions in melanoma using structure-based virtual screening and molecular dynamics simulations.
Biswas R; Chowdhury N; Mukherjee R; Bagchi A
J Mol Graph Model; 2018 Oct; 85():281-293. PubMed ID: 30253283
[TBL] [Abstract][Full Text] [Related]
18. Distinct molecular mechanism for initiating TRAF6 signalling.
Ye H; Arron JR; Lamothe B; Cirilli M; Kobayashi T; Shevde NK; Segal D; Dzivenu OK; Vologodskaia M; Yim M; Du K; Singh S; Pike JW; Darnay BG; Choi Y; Wu H
Nature; 2002 Jul; 418(6896):443-7. PubMed ID: 12140561
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of tumor necrosis factor receptor-associated factor 6 (TRAF6) from grouper, Epinephelus tauvina.
Wei J; Guo M; Gao P; Ji H; Li P; Yan Y; Qin Q
Fish Shellfish Immunol; 2014 Jul; 39(1):61-8. PubMed ID: 24811008
[TBL] [Abstract][Full Text] [Related]
20. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
